vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $47.7M, roughly 1.1× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -5.1%, a 0.3% gap on every dollar of revenue. On growth, READING INTERNATIONAL INC posted the faster year-over-year revenue change (-14.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $4.1M). Over the past eight quarters, READING INTERNATIONAL INC's revenue compounded faster (5.6% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
IRWD vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $50.3M |
| Net Profit | $-2.3M | $-2.6M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | -1.9% |
| Net Margin | -4.8% | -5.1% |
| Revenue YoY | -47.3% | -14.2% |
| Net Profit YoY | -200.9% | -14.5% |
| EPS (diluted) | $0.01 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $50.3M | ||
| Q3 25 | $122.1M | $52.2M | ||
| Q2 25 | $85.2M | $60.4M | ||
| Q1 25 | $41.1M | $40.2M | ||
| Q4 24 | $90.5M | $58.6M | ||
| Q3 24 | $91.6M | $60.1M | ||
| Q2 24 | $94.4M | $46.8M | ||
| Q1 24 | $74.9M | $45.1M |
| Q4 25 | $-2.3M | $-2.6M | ||
| Q3 25 | $40.1M | $-4.2M | ||
| Q2 25 | $23.6M | $-2.7M | ||
| Q1 25 | $-37.4M | $-4.8M | ||
| Q4 24 | $2.3M | $-2.2M | ||
| Q3 24 | $3.6M | $-7.0M | ||
| Q2 24 | $-860.0K | $-12.8M | ||
| Q1 24 | $-4.2M | $-13.2M |
| Q4 25 | 14.3% | -1.9% | ||
| Q3 25 | 61.8% | -0.6% | ||
| Q2 25 | 53.2% | 4.8% | ||
| Q1 25 | -70.7% | -17.2% | ||
| Q4 24 | 34.8% | 2.6% | ||
| Q3 24 | 28.0% | -0.6% | ||
| Q2 24 | 26.5% | -16.4% | ||
| Q1 24 | 14.7% | -16.7% |
| Q4 25 | -4.8% | -5.1% | ||
| Q3 25 | 32.8% | -8.0% | ||
| Q2 25 | 27.7% | -4.4% | ||
| Q1 25 | -90.9% | -11.8% | ||
| Q4 24 | 2.5% | -3.8% | ||
| Q3 24 | 4.0% | -11.7% | ||
| Q2 24 | -0.9% | -27.4% | ||
| Q1 24 | -5.6% | -29.4% |
| Q4 25 | $0.01 | $-0.11 | ||
| Q3 25 | $0.23 | $-0.18 | ||
| Q2 25 | $0.14 | $-0.12 | ||
| Q1 25 | $-0.23 | $-0.21 | ||
| Q4 24 | $0.03 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.31 | ||
| Q2 24 | $-0.01 | $-0.57 | ||
| Q1 24 | $-0.03 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $10.5M |
| Total DebtLower is stronger | — | $185.1M |
| Stockholders' EquityBook value | $-261.8M | $-18.2M |
| Total Assets | $396.9M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $10.5M | ||
| Q3 25 | $140.4M | $8.1M | ||
| Q2 25 | $92.9M | $9.1M | ||
| Q1 25 | $108.5M | $5.9M | ||
| Q4 24 | $88.6M | $12.4M | ||
| Q3 24 | $88.2M | $10.1M | ||
| Q2 24 | $105.5M | $9.3M | ||
| Q1 24 | $121.5M | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | $202.7M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $-18.2M | ||
| Q3 25 | $-264.2M | $-12.1M | ||
| Q2 25 | $-308.2M | $-7.7M | ||
| Q1 25 | $-334.1M | $-8.1M | ||
| Q4 24 | $-301.3M | $-4.4M | ||
| Q3 24 | $-311.3M | $1.6M | ||
| Q2 24 | $-321.7M | $6.5M | ||
| Q1 24 | $-330.5M | $18.0M |
| Q4 25 | $396.9M | $434.9M | ||
| Q3 25 | $396.1M | $435.2M | ||
| Q2 25 | $342.9M | $438.1M | ||
| Q1 25 | $327.2M | $441.0M | ||
| Q4 24 | $350.9M | $471.0M | ||
| Q3 24 | $389.5M | $495.7M | ||
| Q2 24 | $395.6M | $494.9M | ||
| Q1 24 | $438.8M | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $4.3M |
| Free Cash FlowOCF − Capex | $74.6M | $4.1M |
| FCF MarginFCF / Revenue | 156.3% | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $4.3M | ||
| Q3 25 | $47.6M | $295.0K | ||
| Q2 25 | $-15.1M | $1.6M | ||
| Q1 25 | $20.0M | $-7.7M | ||
| Q4 24 | $15.2M | $8.0M | ||
| Q3 24 | $9.9M | $1.3M | ||
| Q2 24 | $33.5M | $-10.4M | ||
| Q1 24 | $45.0M | $-2.8M |
| Q4 25 | $74.6M | $4.1M | ||
| Q3 25 | $47.6M | $-246.0K | ||
| Q2 25 | $-15.1M | $1.2M | ||
| Q1 25 | $19.9M | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | $9.9M | $-1.1M | ||
| Q2 24 | $33.4M | $-10.6M | ||
| Q1 24 | $44.9M | $-4.7M |
| Q4 25 | 156.3% | 8.2% | ||
| Q3 25 | 39.0% | -0.5% | ||
| Q2 25 | -17.7% | 1.9% | ||
| Q1 25 | 48.4% | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | 10.8% | -1.8% | ||
| Q2 24 | 35.4% | -22.7% | ||
| Q1 24 | 60.0% | -10.4% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
